"Henry, remember, these two things are the top priorities now. Also, after these two things are done, pay attention to the three pharmaceutical companies, Pfizer, Johnson & Johnson, and Roche, and when the time is right, buy a large amount of stocks of these three companies."
After Yang Jing finished speaking, Henry's voice rang on the phone, "Boss, are you planning to get involved in the pharmaceutical industry?"
Yang Jing thought for a moment before saying, "Well, you can just do as I say, especially the shares of the three pharmaceutical companies. The more the better!"
"Understood."
After hanging up the phone, Yang Jing leaned back in his chair with his head tilted back, his eyes slightly closed, and one hand gently rubbing his temple.
Although he had used acupuncture to treat many relatives and four masters at home before, Yang Jing was not sure whether acupuncture could cure leukemia. Although he felt that it should be able to cure it, who could say for sure? After all, leukemia is not a disease that occurs in a certain part of the body. It is a disease that involves genes.
This is a terminal illness caused by chromosomal mutation. To be honest, Yang Jing is not completely sure about how to treat such a terminal illness.
Yang Jing has never been the kind of person who only does one-time business. Since it is not certain whether acupuncture can cure Vivian, he must take action now and produce the drug Gleevec as soon as possible.
The birth of Gleevec is inseparable from Brian Drucker and the Swiss pharmaceutical company Ciba-Geigy. Ciba-Geigy had the predecessor drug of Gleevec, but did not know how to use it; Drucker knew how to use the drug but did not have any related drugs.
So, if the two are combined ahead of time, Gleevec should be produced soon.
In fact, originally, after Drucker came into contact with STI571 produced by Ciba-Geigy, it took him less than three years to prepare for human trials. However, due to various wrangling, the first clinical human trial was delayed for a year and a half.
Therefore, in order to avoid this situation, Yang Jing simply waved his golden finger and forced the two together in advance. Those who had no money would be given money, and those who disagreed would be directly bought out of shares to make them agree, thus clearing away all obstacles on the road to the birth of Gleevec.
In this way, Drucker might be able to enter clinical trials within two years. Once KY Investment Fund controls the shares of Ciba-Geigy, such disputes will never happen.
As for the FDA application, that's nothing! If the pharmaceutical company under the KY Investment Fund wants to conduct clinical trials, does it still need to look at the FDA's face? I just get on the boat first and buy the ticket later, what can you do to me?
What? You said the FDA will impose penalties?
Haha, why don't you let the FDA try? If they dare to show such signs, I will immediately replace all the leaders of the FDA! Do you really think that I sponsored George H.W. Bush to get elected as a joke? Do you really think that I sponsored Zipperton as a joke?
Especially since this matter involves Vivian's life, Yang Jing will be even tougher.
Not to mention that Yang Jing knew very well that Gleevec's human trials were just a formality. This drug had actually been born after Drucker met STI571 produced by Ciba-Geigy. Once Drucker said that clinical trials could be carried out, then if he couldn't cure Vivian, Vivian would inevitably become the first subject of the experiment, and Yang Jing firmly believed that this drug could prolong Vivian's life.
No one can stop Yang Jing from forcing Gleevec to be born early! Even if it triggers a small-scale space-time paradox, Yang Jing will endure it by force. It's nothing more than consuming a lot of treasure energy to resist the "heavenly tribulation" of the space-time paradox!
But if Old Mike really left the Dragon Fund because of Vivian, Yang Jing would suffer a huge loss. At this time, the Dragon Fund absolutely could not lose Old Mike.
And through this incident, Yang Jing suddenly realized that his layout in the pharmaceutical field still had great shortcomings.
The pharmaceutical industry will be a very powerful industry in the future, especially the large pharmaceutical companies ranked among the top in the world. Pfizer, Johnson & Johnson, Novartis, and Roche are all very powerful companies.
If you overlooked this before, it’s not too late to start taking action now.
Novartis was not established until 1996, and Pfizer Pharmaceuticals did not secure its position as the world's number one until the launch of Viagra in 1998, which created a sensation. Pfizer is still not up to the mark now.
Including Johnson & Johnson and Roche, they are not very strong yet, so it is still not too late to take action now.
Continue read on readnovelmtl.com
